Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seng Gee Lim

Showing results (1-10 of 241) with videos related to

Pageof 25
Sort By:
Alimentary Pharmacology & Therapeutics|December 28, 2020
Editorial: Biomarkers in HBV and prediction of treatment response - authors' replySeng Gee Lim,
World Journal of Gastroenterology|February 17, 2015
Chronic hepatitis C genotype 1 treatment roadmap for resource constrained settingsSeng Gee Lim
Annals of the Academy of Medicine, Singapore|April 28, 2016
Time for Action on Viral HepatitisSeng Gee Lim
The Lancet. Gastroenterology & Hepatology|July 30, 2023
WHO 2030 HBV elimination goals: a goal too far?Seng Gee Lim
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 4, 2021
ReplySeng Gee Lim
Hepatology International|February 23, 2017
HCV management in resource-constrained countriesSeng Gee Lim
Expert Review of Clinical Pharmacology|January 16, 2014
Telbivudine: a hepatitis B-specific antiviralSeng Gee Lim
Clinical and Molecular Hepatology|December 28, 2025
Comment on the expert consensus on treatment approaches for achieving functional cure in chronic hepatitis BSeng-Gee Lim, Melanie Paff
Expert Review of Vaccines|March 30, 2021
CpG-Adjuvanted Hepatitis B Vaccine (HEPLISAV-B®) UpdateGuan-Huei Lee, Seng-Gee Lim
Gastroenterology Clinics of North America|November 25, 2015
Hepatitis C: An Eastern PerspectiveYock Young Dan, Seng Gee Lim
Pageof 25

Showing results (1-10 of 241) with videos related to

Sort By:
Pageof 25
Alimentary Pharmacology & Therapeutics|December 28, 2020
Editorial: Biomarkers in HBV and prediction of treatment response - authors' replySeng Gee Lim,
World Journal of Gastroenterology|February 17, 2015
Chronic hepatitis C genotype 1 treatment roadmap for resource constrained settingsSeng Gee Lim
Annals of the Academy of Medicine, Singapore|April 28, 2016
Time for Action on Viral HepatitisSeng Gee Lim
The Lancet. Gastroenterology & Hepatology|July 30, 2023
WHO 2030 HBV elimination goals: a goal too far?Seng Gee Lim
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 4, 2021
ReplySeng Gee Lim
Hepatology International|February 23, 2017
HCV management in resource-constrained countriesSeng Gee Lim
Expert Review of Clinical Pharmacology|January 16, 2014
Telbivudine: a hepatitis B-specific antiviralSeng Gee Lim
Clinical and Molecular Hepatology|December 28, 2025
Comment on the expert consensus on treatment approaches for achieving functional cure in chronic hepatitis BSeng-Gee Lim, Melanie Paff
Expert Review of Vaccines|March 30, 2021
CpG-Adjuvanted Hepatitis B Vaccine (HEPLISAV-B®) UpdateGuan-Huei Lee, Seng-Gee Lim
Gastroenterology Clinics of North America|November 25, 2015
Hepatitis C: An Eastern PerspectiveYock Young Dan, Seng Gee Lim
Pageof 25